97 related articles for article (PubMed ID: 27061190)
1. Differences in telomere length between sporadic and familial cutaneous melanoma.
Menin C; Bojnik E; Del Bianco P; Elefanti L; Gianesin K; Keppel S; Stagni C; Mocellin S; Vecchiato A; De Rossi A
Br J Dermatol; 2016 Nov; 175(5):937-943. PubMed ID: 27061190
[TBL] [Abstract][Full Text] [Related]
2. Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.
Burke LS; Hyland PL; Pfeiffer RM; Prescott J; Wheeler W; Mirabello L; Savage SA; Burdette L; Yeager M; Chanock S; De Vivo I; Tucker MA; Goldstein AM; Yang XR
PLoS One; 2013; 8(8):e71121. PubMed ID: 23990928
[TBL] [Abstract][Full Text] [Related]
3. Skin phenotypes can offer some insight about the association between telomere length and cancer susceptibility.
Ribero S; Mangino M; Bataille V
Med Hypotheses; 2016 Dec; 97():7-10. PubMed ID: 27876133
[TBL] [Abstract][Full Text] [Related]
4. Familial and sporadic melanoma: different clinical and histopathological features in the Italian population - a multicentre epidemiological study - by GIPMe (Italian Multidisciplinary Group on Melanoma).
Chiarugi A; Nardini P; Crocetti E; Carli P; De Giorgi V; Borgognoni L; Brandani P; Pimpinelli N; Manganoni AM; Quaglino P;
J Eur Acad Dermatol Venereol; 2012 Feb; 26(2):194-9. PubMed ID: 21429041
[TBL] [Abstract][Full Text] [Related]
5. Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases.
Martinez-Delgado B; Yanowsky K; Inglada-Perez L; de la Hoya M; Caldes T; Vega A; Blanco A; Martin T; Gonzalez-Sarmiento R; Blasco M; Robledo M; Urioste M; Song H; Pharoah P; Benitez J
J Med Genet; 2012 May; 49(5):341-4. PubMed ID: 22493152
[TBL] [Abstract][Full Text] [Related]
6. On the interplay of telomeres, nevi and the risk of melanoma.
Bodelon C; Pfeiffer RM; Bollati V; Debbache J; Calista D; Ghiorzo P; Fargnoli MC; Bianchi-Scarra G; Peris K; Hoxha M; Hutchinson A; Burdette L; Burke L; Fang S; Tucker MA; Goldstein AM; Lee JE; Wei Q; Savage SA; Yang XR; Amos C; Landi MT
PLoS One; 2012; 7(12):e52466. PubMed ID: 23300679
[TBL] [Abstract][Full Text] [Related]
7. Comparison between familial and sporadic cutaneous melanoma in Valencia, Spain.
Nagore E; Botella-Estrada R; Garcia-Casado Z; Requena C; Serra-Guillen C; Llombart B; Sanmartin O; Guillen C
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):931-6. PubMed ID: 18355200
[TBL] [Abstract][Full Text] [Related]
8. Long telomere length and a TERT-CLPTM1 locus polymorphism association with melanoma risk.
Llorca-Cardeñosa MJ; Peña-Chilet M; Mayor M; Gomez-Fernandez C; Casado B; Martin-Gonzalez M; Carretero G; Lluch A; Martinez-Cadenas C; Ibarrola-Villava M; Ribas G
Eur J Cancer; 2014 Dec; 50(18):3168-77. PubMed ID: 25457634
[TBL] [Abstract][Full Text] [Related]
9. Genetics of melanoma progression: the rise and fall of cell senescence.
Bennett DC
Pigment Cell Melanoma Res; 2016 Mar; 29(2):122-40. PubMed ID: 26386262
[TBL] [Abstract][Full Text] [Related]
10. Telomere length and survival in primary cutaneous melanoma patients.
Rachakonda S; Srinivas N; Mahmoudpour SH; Garcia-Casado Z; Requena C; Traves V; Soriano V; Cardelli M; Pjanova D; Molven A; Gruis N; Nagore E; Kumar R
Sci Rep; 2018 Jul; 8(1):10947. PubMed ID: 30026606
[TBL] [Abstract][Full Text] [Related]
11. CDKN2A mutations with p14 loss predisposing to multiple nerve sheath tumours, melanoma, dysplastic naevi and internal malignancies: a case series and review of the literature.
Sargen MR; Merrill SL; Chu EY; Nathanson KL
Br J Dermatol; 2016 Oct; 175(4):785-9. PubMed ID: 26876133
[TBL] [Abstract][Full Text] [Related]
12. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families.
Taylor NJ; Handorf EA; Mitra N; Avril MF; Azizi E; Bergman W; Bianchi-Scarrà G; Bishop DT; Bressac-de Paillerets B; Calista D; Cannon-Albright LA; Cuellar F; Cust AE; Demenais F; Elder DE; Friedman E; Gerdes AM; Ghiorzo P; Goldstein AM; Grazziotin TC; Hansson J; Hayward NK; Hocevar M; Höiom V; Holland EA; Ingvar C; Landi MT; Landman G; Larre-Borges A; Leachman SA; Mann GJ; Nagore E; Olsson H; Palmer J; Perić B; Pjanova D; Puig S; Schmid H; van der Stoep N; Tucker MA; Wadt KAW; Whitaker L; Yang XR; Newton Bishop JA; Gruis NA; Kanetsky PA;
J Invest Dermatol; 2016 May; 136(5):1066-1069. PubMed ID: 26827760
[No Abstract] [Full Text] [Related]
14. Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer.
Capezzone M; Cantara S; Marchisotta S; Busonero G; Formichi C; Benigni M; Capuano S; Toti P; Pazaitou-Panayiotou K; Caruso G; Carli AF; Palummo N; Pacini F
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1852-6. PubMed ID: 21865371
[TBL] [Abstract][Full Text] [Related]
15. Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade.
Martinez-Delgado B; Gallardo M; Tanic M; Yanowsky K; Inglada-Perez L; Barroso A; Rodriguez-Pinilla M; Cañamero M; Blasco MA; Benitez J
Breast Cancer Res Treat; 2013 Sep; 141(2):231-42. PubMed ID: 24036693
[TBL] [Abstract][Full Text] [Related]
16. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K
Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973
[TBL] [Abstract][Full Text] [Related]
17. MDM2 SNP309 promoter polymorphism confers risk for hereditary melanoma.
Thunell LK; Bivik C; Wäster P; Fredrikson M; Stjernström A; Synnerstad I; Rosdahl I; Enerbäck C
Melanoma Res; 2014 Jun; 24(3):190-7. PubMed ID: 24625390
[TBL] [Abstract][Full Text] [Related]
18. Impact of chemotherapy on telomere length in sporadic and familial breast cancer patients.
Benitez-Buelga C; Sanchez-Barroso L; Gallardo M; Apellániz-Ruiz M; Inglada-Pérez L; Yanowski K; Carrillo J; Garcia-Estevez L; Calvo I; Perona R; Urioste M; Osorio A; Blasco MA; Rodriguez-Antona C; Benitez J
Breast Cancer Res Treat; 2015 Jan; 149(2):385-94. PubMed ID: 25528024
[TBL] [Abstract][Full Text] [Related]
19. EDNRB gene variants and melanoma risk in two southern European populations.
Spica T; Fargnoli MC; Hetet G; Bertrand G; Formicone F; Descamps V; Wolkenstein P; Dupin N; Lebbe C; Basset-Seguin N; Saiag P; Cambien F; Grandchamp B; Peris K; Soufir N
Clin Exp Dermatol; 2011 Oct; 36(7):782-7. PubMed ID: 21507037
[TBL] [Abstract][Full Text] [Related]
20. Shorter telomeres associate with a reduced risk of melanoma development.
Nan H; Du M; De Vivo I; Manson JE; Liu S; McTiernan A; Curb JD; Lessin LS; Bonner MR; Guo Q; Qureshi AA; Hunter DJ; Han J
Cancer Res; 2011 Nov; 71(21):6758-63. PubMed ID: 22028319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
